Accumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects.

O6-Methylguanine has been measured in peripheral blood leukocytes of 14 patients during one or more cycles of treatment with procarbazine (daily treatment for 10 days) and in 12 patients during one or more cycles of treatment with dacarbazine (single dose per cycle). Adduct formation at levels up to about 0.4 fmole/microgram DNA was detected in all procarbazine- and all but one dacarbazine-treated patients at some point after treatment. O6-Methylguanine accumulated during procarbazine treatment in a dose-related manner (mean rate of accumulation 2.8 x 10(-4) fmole/microgram DNA per mg/m2 dose) and appeared to approach a plateau by the end of the cycle (above 600 mg/m2 cumulative dose). The average rate of O6-methylguanine formation 2 hr after dacarbazine treatment was 11 +/- 8 x 10(-4) fmole/microgram DNA per mg/m2 dose. Individuals examined on more than one treatment cycle with either drug showed broadly similar methylation responses. The rate of adduct accumulation showed a nonsignificant, negative correlation with the pretreatment lymphocyte levels of the repair enzyme O6-alkylguanine-DNA alkyltransferase (AGT) in the case of procarbazine and no correlation in the case of dacarbazine. No consistent lymphocyte AGT depletion was noted as a result of treatment with either drug. No correlation between O6-methylguanine formation and hematological toxicity was observed. In eight patients showing full remission after treatment with dacarbazine, the value of O6-methylguanine (averaged over all the cycles) was 0.252 +/- 0.120 fmole/microgram DNA while in four patients showing partial or no response it was 0.087 +/- 0.110 fmole/microgram DNA (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[2]  G. Pangalis,et al.  In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. , 1991, Carcinogenesis.

[3]  J. Kaldor,et al.  Epidemiological studies of anticancer drug carcinogenicity. , 1986, IARC scientific publications.

[4]  R. Janzer,et al.  In vivo metabolism and reaction with DNA of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC). , 1986, Biochemical pharmacology.

[5]  S. Hecht,et al.  Detection of O6-methyldeoxyguanosine in human placental DNA. , 1988, Cancer research.

[6]  J. Hotchkiss.  Preformed N-nitroso compounds in foods and beverages. , 1989, Cancer surveys.

[7]  A. Santoro,et al.  Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. , 1982, Blood.

[8]  V. Souliotis,et al.  A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine. , 1989, Cancer research.

[9]  L. Fong,et al.  DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea. , 1990, Carcinogenesis.

[10]  M. D. Topal,et al.  Excision repair of O6-methylguanine synthesized at the rat H-ras N-methyl-N-nitrosourea activation site and introduced into Escherichia coli. , 1989, Carcinogenesis.

[11]  H. Hansen,et al.  RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE Relation to Age, Cumulative Dose of Alkylating Agents, and Time from Chemotherapy , 1987, The Lancet.

[12]  N. Gibson,et al.  Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of alkyltriazenylimidazoles. , 1986, Carcinogenesis.

[13]  R Montesano,et al.  Relevance of nitrosamines to human cancer. , 1984, Carcinogenesis.

[14]  M. Barbacid.  ras genes. , 1987, Annual review of biochemistry.

[15]  P. Kleihues,et al.  DNA methylation in maternal, fetal and neonatal rat tissues following perinatal administration of procarbazine , 2004, Journal of Cancer Research and Clinical Oncology.

[16]  S. Kyrtopoulos,et al.  Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. , 1990, Cancer research.

[17]  N. Thatcher,et al.  O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. , 1991, Cancer research.